Biotech

Companies & Industries News

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 15.12.2021.

#COVID19
#GoodDayBIO
#contractdevelopment
#globalpharma
#FormulationSeries22
#medicaltesting
#china
#NBTintheNews

Companies And Industries

@FiercePharma shared
On Dec 14, 2021
CSL to buy Vifor for $11.7B in biopharma's largest M&A deal this year https://t.co/v9uKILUi0l
Open
CSL to buy Vifor for $11.7B in biopharma's largest M&A deal this year

CSL to buy Vifor for $11.7B in biopharma's largest M&A deal this year

In a move to diversify its business, Australian biopharma CSL has agreed to acquire Vifor Pharma for $11.7 billion. The deal would give CSL—heavily dependent on vaccines and blood plasma ...

@FierceBiotech shared
On Dec 14, 2021
Novartis cuts ties with Mesoblast's failed COVID-19 cell therapy as biotech tries for pivotal phase 3 https://t.co/rw5robfJeu
Open
Novartis cuts ties with Mesoblast's failed COVID-19 cell therapy as biotech tries for pivotal phase 3

Novartis cuts ties with Mesoblast's failed COVID-19 cell therapy as biotech tries for pivotal phase 3

Novartis has canceled an agreement with Mesoblast on a failed COVID-19 cell therapy just as the Australian biotech tries to get a new phase 3 trial off the ground in the hopes the FDA will ...

@IAmBiotech shared
On Dec 13, 2021
#GoodDayBIO: One year after authorization of #COVID19 vaccines, hesitancy remains a challenge. Plus, a deep dive in the plastic problem plaguing our oceans and how biotech can help solve it. https://t.co/lLh7TTPSKq
Open
Good Day BIO: One year after authorization of vaccines, hesitancy remains a challenge

Good Day BIO: One year after authorization of vaccines, hesitancy remains a challenge

Starting a new week with another important anniversary in the COVID-19 timeline, as well as a deep dive in the plastic problem plaguing our oceans (and how biotech can help solve it). ...

@OGConferences shared
On Dec 14, 2021
📢 Formulation US In-Person event update. The team would like to welcome @RecipharmAB to San Diego 01 - 02 February. Take a look at the website and see how you can meet them on-site. https://t.co/WozTm2uKUQ #FormulationSeries22 #contractdevelopment #globalpharma https://t.co/TEjNupQHaG
Open
Formulation & Delivery US:

Formulation & Delivery US:

Formulation & Delivery US: 01 – 02 February 2022 | San Diego, USA + Digital Day: 03 February 2022 | Online Join leaders, experts and researchers at Formulation & Delivery US: In-Person, ...

@biospace shared
On Dec 13, 2021
Now trading in Shanghai, BeiGene unveils promising phase III results #medicaltesting #china https://t.co/zdCStpsNp8
Open
Now Trading in Shanghai, BeiGene Unveils Promising Phase III Results

Now Trading in Shanghai, BeiGene Unveils Promising Phase III Results

BeiGene raised $3.3 billion on Shanghai’s STAR market, making it the first company to trade its shares in Shanghai, Hong Kong, and New York.

@ideapharma shared
On Dec 13, 2021
RT @JohnCendpts: $BLU up 62% Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis By @Nicole_DeFeudis https://t.co/EAYJ1fmgSi
Open
Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis

Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis

Do investors want the good news, or the bad news first? Bellus went with the good news, sharing that its chronic cough contender hit the primary endpoint in a Phase IIb trial, lining it up ...

@kiranshaw shared
On Dec 15, 2021
Omicron Problem For Doctors: How To Know What To Prescribe - can we please track severity of Omicron? Thus far it is only showing mild symptoms. Why is no one sharing comparative data between Delta n Omicron patients? India shd create a database https://t.co/dIRlXxWCd8
Open
Omicron Problem For Doctors: How To Know What To Prescribe

Omicron Problem For Doctors: How To Know What To Prescribe

The omicron variant presents a new problem for doctors: Some drugs may work better than others, but knowing what to prescribe will hinge on quickly figuring out what variant of Covid-19 a ...

@NatureBiotech shared
On Dec 10, 2021
Study advances knowledge of what happens in our cells after exercise #NBTintheNews via @Sydney_Uni https://t.co/hKImTLADh4
Open
Study advances knowledge of what happens in our cells after exercise

Study advances knowledge of what happens in our cells after exercise

An international team of researchers has developed a new approach to pinpoint which proteins in our cells are most critical for increasing sugar absorption after exercise - an …